BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32162328)

  • 1. CD14
    Storti P; Vescovini R; Costa F; Marchica V; Toscani D; Dalla Palma B; Craviotto L; Malavasi F; Giuliani N
    Br J Haematol; 2020 Aug; 190(3):430-436. PubMed ID: 32162328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition.
    Treffers LW; Ten Broeke T; Rösner T; Jansen JHM; van Houdt M; Kahle S; Schornagel K; Verkuijlen PJJH; Prins JM; Franke K; Kuijpers TW; van den Berg TK; Valerius T; Leusen JHW; Matlung HL
    Cancer Immunol Res; 2020 Jan; 8(1):120-130. PubMed ID: 31690649
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Bolzoni M; Ronchetti D; Storti P; Donofrio G; Marchica V; Costa F; Agnelli L; Toscani D; Vescovini R; Todoerti K; Bonomini S; Sammarelli G; Vecchi A; Guasco D; Accardi F; Palma BD; Gamberi B; Ferrari C; Neri A; Aversa F; Giuliani N
    Haematologica; 2017 Apr; 102(4):773-784. PubMed ID: 28057743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between P-selectin glycoprotein ligand-1 and pathogenesis in acute coronary syndrome assessed by optical coherence tomography.
    Ozaki Y; Imanishi T; Teraguchi I; Nishiguchi T; Orii M; Shiono Y; Shimamura K; Ishibashi K; Tanimoto T; Yamano T; Ino Y; Yamaguchi T; Kubo T; Akasaka T
    Atherosclerosis; 2014 Apr; 233(2):697-703. PubMed ID: 24583418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset.
    Draude G; von Hundelshausen P; Frankenberger M; Ziegler-Heitbrock HW; Weber C
    Am J Physiol; 1999 Apr; 276(4):H1144-9. PubMed ID: 10199836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns.
    Pedraza-Sánchez S; Hise AG; Ramachandra L; Arechavaleta-Velasco F; King CL
    Clin Vaccine Immunol; 2013 Jul; 20(7):962-71. PubMed ID: 23595503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma.
    Overdijk MB; Verploegen S; Bögels M; van Egmond M; Lammerts van Bueren JJ; Mutis T; Groen RW; Breij E; Martens AC; Bleeker WK; Parren PW
    MAbs; 2015; 7(2):311-21. PubMed ID: 25760767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab.
    Baumann N; Arndt C; Petersen J; Lustig M; Rösner T; Klausz K; Kellner C; Bultmann M; Bastian L; Vogiatzi F; Leusen JHW; Burger R; Schewe DM; Peipp M; Valerius T
    Front Immunol; 2022; 13():949140. PubMed ID: 36052078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis.
    Frankenberger M; Sternsdorf T; Pechumer H; Pforte A; Ziegler-Heitbrock HW
    Blood; 1996 Jan; 87(1):373-7. PubMed ID: 8547664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the proportion of non-classic (CD14+CD16+) monocytes/macrophages in peripheral blood and gingiva of healthy individuals and patients with chronic periodontitis.
    Jagannathan R; Lavu V; Rao SR
    J Periodontol; 2014 Jun; 85(6):852-8. PubMed ID: 24001047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD38
    Sarkar S; Chauhan SKS; Daly J; Natoni A; Fairfield H; Henderson R; Nolan E; Swan D; Hu J; Reagan MR; O'Dwyer M
    Cancer Immunol Immunother; 2020 Mar; 69(3):421-434. PubMed ID: 31919623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma.
    Panaampon J; Kariya R; Okada S
    Cancer Immunol Immunother; 2022 May; 71(5):1017-1031. PubMed ID: 34545416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis.
    Nockher WA; Scherberich JE
    Infect Immun; 1998 Jun; 66(6):2782-90. PubMed ID: 9596748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients.
    Amir O; Spivak I; Lavi I; Rahat MA
    Mediators Inflamm; 2012; 2012():616384. PubMed ID: 23226928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Monocyte and Macrophage Homeostasis in Periodontitis.
    Almubarak A; Tanagala KKK; Papapanou PN; Lalla E; Momen-Heravi F
    Front Immunol; 2020; 11():330. PubMed ID: 32210958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma.
    Cho N; Ko S; Shokeen M
    Mol Imaging Biol; 2021 Apr; 23(2):186-195. PubMed ID: 32964391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting.
    Viola D; Dona A; Caserta E; Troadec E; Besi F; McDonald T; Ghoda L; Gunes EG; Sanchez JF; Khalife J; Martella M; Karanes C; Htut M; Wang X; Rosenzweig M; Chowdhury A; Sborov D; Miles RR; Yazaki PJ; Ebner T; Hofmeister CC; Forman SJ; Rosen ST; Marcucci G; Shively J; Keats JJ; Krishnan A; Pichiorri F
    Leukemia; 2021 Jan; 35(1):189-200. PubMed ID: 32296125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation.
    Hofer TP; Zawada AM; Frankenberger M; Skokann K; Satzl AA; Gesierich W; Schuberth M; Levin J; Danek A; Rotter B; Heine GH; Ziegler-Heitbrock L
    Blood; 2015 Dec; 126(24):2601-10. PubMed ID: 26443621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.
    Fingerle G; Pforte A; Passlick B; Blumenstein M; Ströbel M; Ziegler-Heitbrock HW
    Blood; 1993 Nov; 82(10):3170-6. PubMed ID: 7693040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Native and Minimally Modified Low-density Lipoprotein on the Activation of Monocyte Subsets.
    Blanco-Favela F; Espinosa-Luna JE; Chávez-Rueda AK; Madrid-Miller A; Chávez-Sánchez L
    Arch Med Res; 2017 Jul; 48(5):432-440. PubMed ID: 29133194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.